Financial results - TORUS PHARMA COMPANY SRL

Financial Summary - Torus Pharma Company Srl
Unique identification code: 31885689
Registration number: J2013007825406
Nace: 4646
Sales - Ron
824.869
Net Profit - Ron
7.212
Employees
4
Open Account
Company Torus Pharma Company Srl with Fiscal Code 31885689 recorded a turnover of 2024 of 824.869, with a net profit of 7.212 and having an average number of employees of 4. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Torus Pharma Company Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 954.814 982.073 762.476 771.007 976.831 1.315.552 924.052 999.272 1.500.604 824.869
Total Income - EUR 964.937 1.002.467 849.964 786.953 995.803 1.332.353 1.207.741 1.039.457 1.513.851 884.385
Total Expenses - EUR 930.661 985.118 810.710 763.424 983.064 1.299.902 1.171.172 1.103.487 1.589.727 873.700
Gross Profit/Loss - EUR 34.276 17.349 39.254 23.529 12.739 32.451 36.568 -64.030 -75.877 10.685
Net Profit/Loss - EUR 20.646 9.907 14.129 15.800 3.647 23.836 23.147 -64.030 -75.877 7.212
Employees 7 7 5 6 7 7 5 5 5 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -44.7%, from 1.500.604 euro in the year 2023, to 824.869 euro in 2024. The Net Profit increased by 7.212 euro, from 0 euro in 2023, to 7.212 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Torus Pharma Company Srl

Rating financiar

Financial Rating -
TORUS PHARMA COMPANY SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Torus Pharma Company Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Torus Pharma Company Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Torus Pharma Company Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Torus Pharma Company Srl - CUI 31885689

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 103.625 324.762 347.835 332.647 369.764 414.210 314.588 275.221 270.366 579.426
Current Assets 428.722 555.184 504.056 650.355 645.339 745.652 498.017 577.900 646.254 547.081
Inventories 114.734 63.052 94.915 298.214 161.286 198.018 245.040 170.332 146.262 179.425
Receivables 129.169 306.034 348.212 328.249 414.241 440.854 170.447 257.187 397.320 302.949
Cash 184.820 186.099 60.929 23.892 69.812 106.780 82.530 150.381 102.672 64.707
Shareholders Funds 20.589 30.290 30.344 6.303 19.918 52.184 188.399 29.457 -46.509 261.156
Social Capital 20.972 20.762 20.411 20.037 47.794 142.441 284.244 191.390 190.810 189.743
Debts 515.448 853.430 835.635 977.749 1.016.647 1.131.403 653.447 822.426 962.281 864.304
Income in Advance 0 0 0 0 0 0 1.395 1.400 1.396 1.388
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 547.081 euro in 2024 which includes Inventories of 179.425 euro, Receivables of 302.949 euro and cash availability of 64.707 euro.
The company's Equity was valued at 261.156 euro, while total Liabilities amounted to 864.304 euro. Equity increased by 307.404 euro, from -46.509 euro in 2023, to 261.156 in 2024. The Debt Ratio was 76.7% in the year 2024.

Risk Reports Prices

Reviews - Torus Pharma Company Srl

Comments - Torus Pharma Company Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.